What is CRSP's current stock price?

As of now, CRSP is trading at $53.51, with a daily change of -1.29%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP

CRISPR Therapeutics

$53.51

-$0.70 | -1.29%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$78.48

MKT CAP

$5.10B

52W Low

$30.06

VOL

$1.22M

P/E Ratio

N/A

AVG VOL

$1.70M

RSI

43.18

TREND

Downtrend

CRSP Stock IQ

Login to see CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRSP Target Price

Login to display

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Outperform the market

CRSP Rewards

Trading below its fair value

CRSP Price Performance

$55.86 (-4.21%)

$67.21 (-20.38%)

$54.88 (-2.50%)

$40.49 (+32.16%)

1year

6month

3month

1month

CRSP Analysts Opinion

CRSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CRSP Analysts Opinion

CRSP Analysts opinion is positive and also has improved from the past 3 months

CRSP Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

CRSP Street Sentiment

CRSP Street Sentiment is extremely bullish and have positive views on the near-term outlook

CRSP Risk Level

CRSP has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

83%

17%

Positive

Negative

10 out of 12
events present

2 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$53.51

Resistance
Price

$51.11

Current Price Range

$58.19

Show methods +

Linked to CRSP

IQ

Close Price

Change

VCEL

4.00

37.40

-3.03%

IBRX

4.41

5.52

+39.75%

CLDI

N/A

1.03

-0.96%

BNTX

4.28

109.00

+2.76%

BEAM

4.33

31.22

-2.59%

Recently Viewed

Close Price

Change

CRSP

CRISPR Therapeutics

53.51

-1.29%

BOX

Box

25.85

-2.71%

ASTS

AST SpaceMobile

115.77

+14.34%

ALC

Alcon Ordinary

79.00

-0.82%

ALT

Altimmune

4.24

0.00%

CRSP Latest Analysis +

CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors. CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21 signifying a -4.71% move from its prior days close.

Thu Jan 15, 2026

$54.21 | -4.71%

Activity

Momentum

Crispr Therapeutics: Patience And Opportunity Through Volatility.

Wed Jan 14, 2026

$56.89 | +1.26%

Potential

CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Mon Jan 12, 2026

$55.30 | +2.71%

Activity

CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?. Based on the average brokerage recommendation (ABR) CRISPR Therapeutics (CRSP) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So is the stock worth buying?

Mon Jan 12, 2026

$55.30 | +2.71%

Potential

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference. CAMBRIDGE Mass. Jan. 07 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics Inc. (NASDAQ:NTLA) a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday January 14 2026 at 9:00 a.m. PT.

Wed Jan 7, 2026

$57.99 | -0.34%

Activity

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Heres Why. The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16 representing a 2.58% change from its previous close.

Mon Jan 5, 2026

$55.16 | +2.67%

Momentum

Cathie Woods Biotech Trend: Twist Beam CRISPR Latest Stock Picks. The massive rotation currently unfolding within See the chart and price action here.As 2025 draws to a close ARK legacy winners such as TSLA) andRKLB) to fund a multi-million dollar accumulation of gene-editing pioneers.ARK Invest has been specifically loading up on shares of

Wed Dec 31, 2025

$52.44 | -1.41%

Activity

Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP). CRISPR Therapeutics AG (NASDAQ:CRSP) is among the 12 Best Genomics Stocks to Invest In. TheFly published on November 26 2025 that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while reducing its price target from $82 to $74. The firm stated that the modification came after revisions to its business model following the [….]

Wed Dec 31, 2025

$52.44 | -1.41%

Activity

Rating

FAQ About CRSP Stock Insights

What is CRSP current stock price?

What are CRSP stock strengths?

What is CRSP Risk Level?

What is CRSP market cap and volume?

What is CRSP current Stock IQ?

Should I buy CRSP stock right now?

Is CRSP a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRSP?

What does a 'Strong Sell' rating mean for CRSP?

What factors influence CRSP's Stock IQ?

Explore our CRSP Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CRSP Stock Strategies
Effective Risk Management

FIND US ON

Receive our CRSP Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CRSP

CRISPR Therapeutics

Set Alerts

Current Price

$53.51

-$0.70 | -1.29%

52W High

$78.48

MKT CAP

$5.10B

52W Low

$30.06

VOL

$1.22M

P/E Ratio

N/A

AVG VOL

$1.70M

RSI

43.18

TREND

Downtrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Stock Insights

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Outperform the market

CRSP Rewards

Trading below its fair value

Linked to CRSP

Symbol

IQ

Close

Change

VCEL

4.00

37.40

-3.03%

IBRX

4.41

5.52

+39.75%

CLDI

N/A

1.03

-0.96%

BNTX

4.28

109.00

+2.76%

BEAM

4.33

31.22

-2.59%

CRSP Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

CRSP Street Sentiment

CRSP Street Sentiment is extremely bullish and have positive views on the near-term outlook

CRSP Risk Level

CRSP has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

83%

17%

Positive

Negative

10 out of 12
events present

2 out of 12
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$53.51

Resistance
Price

$51.11

Current Price Range

$58.19

Show methods +

Latest Analysts Recommendations

Date

Action

Rating

Firm

Dec 31, 2025

Reiterate

Buy

Chardan

Dec 24, 2025

Reiterate

Buy

Needham

Dec 24, 2025

Reiterate

Outperform

Citizens

Nov 13, 2025

Reiterate

Buy

Citigroup

Oct 17, 2025

Reiterate

Buy

B of A Securities

CRSP Stock IQ

Login to unlock CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRSP Latest Analysis

CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors. CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21 signifying a -4.71% move from its prior days close.

Thu Jan 15, 2026

$54.21 | -4.71%

Activity

Momentum

Crispr Therapeutics: Patience And Opportunity Through Volatility.

Wed Jan 14, 2026

$56.89 | +1.26%

Potential

CRISPR Therapeutics AG (CRSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Mon Jan 12, 2026

$55.30 | +2.71%

Activity

CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?. Based on the average brokerage recommendation (ABR) CRISPR Therapeutics (CRSP) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So is the stock worth buying?

Mon Jan 12, 2026

$55.30 | +2.71%

Potential

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference. CAMBRIDGE Mass. Jan. 07 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics Inc. (NASDAQ:NTLA) a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday January 14 2026 at 9:00 a.m. PT.

Wed Jan 7, 2026

$57.99 | -0.34%

Activity

CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Heres Why. The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16 representing a 2.58% change from its previous close.

Mon Jan 5, 2026

$55.16 | +2.67%

Momentum

Cathie Woods Biotech Trend: Twist Beam CRISPR Latest Stock Picks. The massive rotation currently unfolding within See the chart and price action here.As 2025 draws to a close ARK legacy winners such as TSLA) andRKLB) to fund a multi-million dollar accumulation of gene-editing pioneers.ARK Invest has been specifically loading up on shares of

Wed Dec 31, 2025

$52.44 | -1.41%

Activity

Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP). CRISPR Therapeutics AG (NASDAQ:CRSP) is among the 12 Best Genomics Stocks to Invest In. TheFly published on November 26 2025 that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while reducing its price target from $82 to $74. The firm stated that the modification came after revisions to its business model following the [….]

Wed Dec 31, 2025

$52.44 | -1.41%

Activity

Rating

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CRSP. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CRSP Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRSP Stock trends

CRSP Stock performance

CRSP Stock analysis

CRSP investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP Stock IQ

CRSP Target Price

CRSP Analysts Opinion

CRSP Street Sentiment

CRSP Risk Level

CRSP Performance Sentiment

Technical Price Levels

Explore our CRSP Stock insights

Receive our CRSP Daily Alerts

CRSP Street Sentiment

CRSP Risk Level

Technical Price Levels

Latest Analysts Recommendations

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CRSP. We're here to help you make informed investment decisions today.

Receive our CRSP Daily Alerts

CRSP Alerts